Keith Westby - Dec 1, 2022 Form 4 Insider Report for IVERIC bio, Inc. (ISEE)

Role
SVP & COO
Signature
/s/ Todd D.C. Anderman, as Attorney-in-Fact for Keith Westby
Stock symbol
ISEE
Transactions as of
Dec 1, 2022
Transactions value $
-$230,289
Form type
4
Date filed
12/5/2022, 04:37 PM
Previous filing
Nov 3, 2022
Next filing
Dec 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISEE Common Stock Sale -$230K -10K -14.37% $22.96 59.8K Dec 1, 2022 Direct F1, F2, F3
transaction ISEE Common Stock Options Exercise $52.1K +5.2K +8.7% $10.03 65K Dec 2, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISEE Stock Option (right to buy) Options Exercise -$52.1K -5.2K -100% $10.03 0 Dec 2, 2022 Common Stock 5.2K $10.03 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2021.
F2 The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $22.62 to $23.84 per share on December 1, 2022. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
F3 This total includes 661 shares acquired by the Reporting Person on September 15, 2022 under the Registrant's 2016 Employee Stock Purchase Plan that were not previously reported.
F4 This option was granted on December 29, 2012 and is currently excisable for all shares underlying the option.